Daniela Dragoโ€™s Post

View profile for Daniela Drago

Regulatory Expert | Partner | Advisor | Author & Speaker | Professor | Board Member

๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜€ ๐—•๐—ฎ๐—ฐ๐—ธ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—ฅ๐—ฒ๐—น๐—ถ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ข๐—ป ๐—š๐— ๐—ฃ - ๐—ฃ๐—œ๐—–/๐—ฆ ๐—Ÿ๐—ฎ๐˜๐—ฒ๐˜€๐˜ ๐—ฆ๐˜๐—ฟ๐—ฎ๐˜๐—ฒ๐—ด๐—ถ๐—ฐ ๐—ฃ๐—น๐—ฎ๐—ป In case you missed it, theย Pharmaceutical Inspection Co-operation Scheme (PIC/S) published its 2023-2027 strategic plan. PIC/S is a cooperative arrangement between regulatory authorities in the field of Good Manufacturing Practice (GMP) of medicinal products for human or veterinary use. PIC/S is comprised of more than 50 participating authorities. ๐™’๐™๐™ฎ ๐™„๐™ฉ ๐™ˆ๐™–๐™ฉ๐™ฉ๐™š๐™ง๐™จ: This strategic plan highlights the focus of PIC/S over the next five years. The priorities outlined in the document are ๐Ÿ”น Inspection reliance ๐Ÿ”น Preferred forum for GxP harmonization ๐Ÿ”น Centre of excellence for training ๐Ÿ”น Preparing regulatory inspectorates for the future ๐Ÿ”น Partnership and stakeholder cooperation, and ๐Ÿ”น PIC/S operational capacity #drugdevelopment, #regulatoryreliance, #inspections, #GMP

To view or add a comment, sign in

Explore topics